GB9720797D0 - Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome - Google Patents

Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome

Info

Publication number
GB9720797D0
GB9720797D0 GBGB9720797.1A GB9720797A GB9720797D0 GB 9720797 D0 GB9720797 D0 GB 9720797D0 GB 9720797 A GB9720797 A GB 9720797A GB 9720797 D0 GB9720797 D0 GB 9720797D0
Authority
GB
United Kingdom
Prior art keywords
treatment
pharmaceutical composition
inflammatory bowel
bowel disease
bowel syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9720797.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB9720797.1A priority Critical patent/GB9720797D0/en
Publication of GB9720797D0 publication Critical patent/GB9720797D0/en
Priority to AU92731/98A priority patent/AU9273198A/en
Priority to EP98945401A priority patent/EP1019038A1/en
Priority to CA002304516A priority patent/CA2304516A1/en
Priority to PCT/GB1998/002933 priority patent/WO1999016436A1/en
Priority to JP2000513572A priority patent/JP2001517697A/en
Priority to ZA988920A priority patent/ZA988920B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9720797.1A 1997-09-30 1997-09-30 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome Ceased GB9720797D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9720797.1A GB9720797D0 (en) 1997-09-30 1997-09-30 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
AU92731/98A AU9273198A (en) 1997-09-30 1998-09-29 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
EP98945401A EP1019038A1 (en) 1997-09-30 1998-09-29 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
CA002304516A CA2304516A1 (en) 1997-09-30 1998-09-29 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
PCT/GB1998/002933 WO1999016436A1 (en) 1997-09-30 1998-09-29 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
JP2000513572A JP2001517697A (en) 1997-09-30 1998-09-29 Pharmaceutical compositions for treating inflammatory bowel disease and irritable bowel syndrome
ZA988920A ZA988920B (en) 1997-09-30 1998-09-30 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9720797.1A GB9720797D0 (en) 1997-09-30 1997-09-30 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome

Publications (1)

Publication Number Publication Date
GB9720797D0 true GB9720797D0 (en) 1997-12-03

Family

ID=10819864

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9720797.1A Ceased GB9720797D0 (en) 1997-09-30 1997-09-30 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome

Country Status (7)

Country Link
EP (1) EP1019038A1 (en)
JP (1) JP2001517697A (en)
AU (1) AU9273198A (en)
CA (1) CA2304516A1 (en)
GB (1) GB9720797D0 (en)
WO (1) WO1999016436A1 (en)
ZA (1) ZA988920B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1225897B1 (en) * 1999-11-01 2004-09-08 RHODES, John Composition for treatment of constipation and irritable bowel syndrome
US7081475B2 (en) 2001-09-14 2006-07-25 Prolx Pharmaceuticals Corp. Wortmannin analogs and methods of using same
WO2006084913A2 (en) * 2005-02-11 2006-08-17 Nolabs Ab Device for treatment of rectal disorders, and manufacturing process for the same, involving nitric oxide
EP1690557A1 (en) * 2005-02-11 2006-08-16 NOLabs AB Device for treatment of rectal disorders, and manufacturing process for the same
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
AU2012203798B2 (en) * 2005-08-12 2013-11-07 Northrop Grumman Systems Corporation O-nitro compounds, pharmaceutical compositons thereof and uses thereof
US20070135380A1 (en) * 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
EP1941876A1 (en) * 2006-12-28 2008-07-09 Lacer, S.A. Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension
US8471041B2 (en) 2010-02-09 2013-06-25 Alliant Techsystems Inc. Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
US8664247B2 (en) 2011-08-26 2014-03-04 Radiorx, Inc. Acyclic organonitro compounds for use in treating cancer
EP2763667B1 (en) 2011-10-07 2022-10-26 EpicentRx, Inc. Organonitro thioether compounds and medical uses thereof
WO2013052803A2 (en) 2011-10-07 2013-04-11 Radiorx, Inc. Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
US10342778B1 (en) 2015-10-20 2019-07-09 Epicentrx, Inc. Treatment of brain metastases using organonitro compound combination therapy
US9987270B1 (en) 2015-10-29 2018-06-05 Epicentrix, Inc. Treatment of gliomas using organonitro compound combination therapy
CA3011103A1 (en) 2016-01-11 2017-07-20 Epicentrx, Inc. Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
WO2017137489A1 (en) * 2016-02-12 2017-08-17 Dsm Ip Assets B.V. Anti-methanogenic compositions and uses thereof
CA3040479A1 (en) 2016-10-14 2018-04-19 Epicentrx, Inc. Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
MX2020000265A (en) 2017-07-07 2020-07-22 Epicentrx Inc Compositions for parenteral administration of therapeutic agents.
US11510901B2 (en) 2018-01-08 2022-11-29 Epicentrx, Inc. Methods and compositions utilizing RRx-001 combination therapy for radioprotection
CN110200921B (en) * 2019-06-19 2020-11-17 华中科技大学 Anti-inflammatory liposome with targeting effect and preparation and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428925A (en) * 1981-12-18 1984-01-31 Key Pharmaceuticals, Inc. Sustained release glycerol trinitrate
DE3728563A1 (en) * 1987-08-27 1989-03-09 Pohl Boskamp Gmbh Chem Pharma MEDICINAL PRODUCT CONTAINING N-ALKYLSCOPOLAMININE SALT AND NITROGLYCERIN, METHOD FOR THE PRODUCTION AND USE THEREOF
US5004601A (en) * 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
WO1993012068A1 (en) * 1991-12-11 1993-06-24 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5632981A (en) * 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
PT661045E (en) * 1992-09-18 2002-11-29 Yamanouchi Pharma Co Ltd PREPARATION IN HYDROGEL OF PROLONGED LIBERATION
JPH06227969A (en) * 1993-02-02 1994-08-16 Masayasu Sugihara Method for improving enteric property of medicine and medicine composition obtained thereby
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
DE4420523A1 (en) * 1994-06-13 1995-12-14 Cassella Ag Treating and preventing SIRS, e.g. in shock, arthritis or peritonitis
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
ZA988920B (en) 1999-06-09
EP1019038A1 (en) 2000-07-19
CA2304516A1 (en) 1999-04-08
AU9273198A (en) 1999-04-23
WO1999016436A1 (en) 1999-04-08
JP2001517697A (en) 2001-10-09

Similar Documents

Publication Publication Date Title
ZA988920B (en) Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
HUP0103147A3 (en) Pharmaceutical composition comprising glp1 and their use for the treatment of functional dyspepsia and/or irritable bowel syndrome
HK1022835A1 (en) Pharmaceutical composition for treatment of diabetes
ZA987800B (en) Pharmaceutical composition of meloxicam
IL117417A (en) Pharmaceutical composition comprising rapamycin for treating cardiac inflammatory disease and its preparation
HUP0002183A3 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL132145A0 (en) Methods and compositions for treating inflammatory bowel disease
ID18663A (en) COMPOSITION OF PHARMACEUTICAL PLATED PHARMACEUTICALS
PT907364E (en) PHARMACEUTICAL COMPOSITION OF SUSTAINED LIBERTACAO
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
GB9706842D0 (en) Pharmaceutical compositions for the treatment of rhinitis
HUP0002346A3 (en) Pharmaceutical composition for the treatment of mental illness in mammals
HUP0003244A2 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)